Package 71335-2499-4

{"route": ["ORAL"], "spl_id": "28a2d1e3-d88b-4312-99a9-54592acd5a27", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["bf5e933c-8a84-4dd7-a05d-6c4a82b6c965"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-1)", "package_ndc": "71335-2499-1", "marketing_start_date": "20240923"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-2)", "package_ndc": "71335-2499-2", "marketing_start_date": "20240923"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-3)", "package_ndc": "71335-2499-3", "marketing_start_date": "20240923"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-4)", "package_ndc": "71335-2499-4", "marketing_start_date": "20240923"}, {"sample": false, "description": "8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-5)", "package_ndc": "71335-2499-5", "marketing_start_date": "20240923"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2499-6)", "package_ndc": "71335-2499-6", "marketing_start_date": "20240923"}], "brand_name": "Bupropion hydrochloride", "product_id": "71335-2499_28a2d1e3-d88b-4312-99a9-54592acd5a27", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-2499", "generic_name": "Bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA215568", "marketing_category": "ANDA", "marketing_start_date": "20221215", "listing_expiration_date": "20261231"}